On ECHEMI
Home > Drugs > Levamisole Hydrochloride Tablets

Levamisole Hydrochloride Tablets

Function and Efficacy

This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune preparation functions.

Ingredients

The main ingredient of this product is: Levamisole hydrochloride. Its chemical name is: (S)-(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride.

Name Description Content CAS NO. Manufacturer
Levamisole hydrochlorideIngredients

It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the worm muscles, and reduces energy production; it depolarizes the nerve muscles, causing continuous muscle contraction and paralysis; its cholinergic effect is beneficial to the excretion of the worm; it may have an inhibitory effect on the microtubule structure of the worm; it has immune regulation and immune excitation functions.

More
16595-80-5 7

Appearance

This product is a white tablet or sugar-coated tablet, which appears white after removing the coating.

Indication

It has good efficacy against ascaris, hookworm, pinworm and strongyloidiasis. Since the single dose of this product has a high efficacy, it is suitable for group treatment. It is more active than ethopropazine against adult worms and microfilariae of Bancroftian filariasis, Malayan Brugia and Onchocerca volvulus, but the long-term efficacy is poor.

Usage and Dosage

① Ascaris removal: Oral, 1.5-2.5 mg/kg for adults, taken on an empty stomach or before bedtime, 2-3 mg/kg for children. ② Hookworm removal: Oral, 1.5-2.5 mg/kg, once a night, for 3 consecutive days. ③ Treatment of filariasis: 4-6 mg/kg, divided into 2-3 doses, for 3 consecutive days.

Adverse Reactions

Generally mild. Nausea, vomiting, abdominal pain, etc., a few may have taste disorders, fatigue, dizziness, headache, joint pain, confusion, insomnia, fever, flu-like symptoms, low blood pressure, vasculitis, rash, photosensitivity dermatitis, etc., proteinuria, individual granulocytopenia, thrombocytopenia, a few even have agranulocytosis (usually reversible), often occurs in patients with rheumatism or tumors. In addition, it can cause immediate and Arthus allergic reactions, which may be atopic reactions caused by stimulating T cells. Individual cases may have ataxia, paresthesia or blurred vision.

Precautions

It is contraindicated for patients with impaired liver and kidney function, active hepatitis, early pregnancy, or pre-existing schistosomiasis.

Special Population Medication

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

Drug Interactions

(1) It can be used in combination with pyrantel to treat severe hookworm infections and improve the effectiveness of expelling American hookworms. (2) It can be used in combination with thiabendazole to treat mixed intestinal nematode infections. (3) It can be used sequentially with diethylcarbamazine citrate to treat filarial infections. (4) It should not be used in combination with tetrachloroethylene to avoid increasing its toxicity.

Storage

Store in sealed container (room temperature 10-30℃).

Packaging Specification

25mg

Validity Period

24 months

Manufacturer

Hainan Pharmaceutical FACTORY Co., Ltd.

  • Founded in:

    2001-07-09
  • Address:

    Hebei West Road, Wuzhishan City, Hainan Province
  • Tax NO.:

    91469001730040768G
  • Registered Funds:

    12.8 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.